Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incidence of Post-intravitreal Anti-VEGF Endophthalmitis at Thammasat University Hospital
TCTR20141119002Completed
- Sponsor
- Faculty of Medicine, Thammasat University
- Start
- Jul 2014
- Countries
- 1
01
Overview
Open-label, single-arm trial in exudative macular degeneration, diabetic macular edema (DME) and Vein occlusion (RVO), sponsored by Faculty of Medicine, Thammasat University. Primary endpoint: Incidence of post-intravitreal anti-VEGF endophthalmitis. Started Jul 2014; status: completed.
02
Conditions
exudative macular degenerationdiabetic macular edema (DME)Vein occlusion (RVO)
Beyond the preview
Go deeper on TCTR20141119002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20141119002.